Immediate Impact
1 by Nobel laureates 57 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
2024 Standout
Works of Laurence Skillern being referenced
A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause
2020
Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin‐induced dysmenorrhea
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Laurence Skillern | 218 | 70 | 111 | 160 | 19 | 410 | |
| Serdar Özşener | 161 | 93 | 77 | 73 | 22 | 348 | |
| Serena Ottanelli | 192 | 20 | 76 | 133 | 26 | 397 | |
| S. Dendrinos | 69 | 137 | 118 | 79 | 16 | 399 | |
| P.G. Whittaker | 86 | 61 | 153 | 95 | 13 | 457 | |
| Sophia Stone | 89 | 72 | 65 | 58 | 23 | 419 | |
| Kresten Rubeck Petersen | 73 | 82 | 126 | 50 | 21 | 375 | |
| Annamaria Giacobbe | 170 | 48 | 50 | 107 | 24 | 362 | |
| Anna Bertocco | 114 | 49 | 26 | 66 | 22 | 374 | |
| Sophia Sakka | 34 | 41 | 42 | 172 | 31 | 439 | |
| Filiz F. Yanık | 131 | 21 | 28 | 99 | 29 | 386 |
All Works
Loading papers...